| 321 |
25C-NBOH |
recent,phenethylamine |
| 413 |
25I-NBOH |
recent,phenethylamine |
| 241 |
3-BMC |
cathinone,recent |
| 366 |
5F CUMYL-PICA |
recent,cannabinoid |
| 377 |
5F-ADB |
recent,cannabinoid |
| 377 |
5F-AEB |
recent,cannabinoid |
| 362 |
5F-AMB-PICA |
recent,cannabinoid |
| 375 |
AM2201 8-quinolinyl carboxamide |
cannabinoid,recent |
| 302 |
5α-Androstan-3,6,17-trione |
USCSA,H.R.4771,recent |
| 213 |
4-Bromoamphetamine |
recent,phenethylamine |
| 362 |
6-Bromo-androsta-1,4-diene-3,17-dione |
USCSA,H.R.4771,recent |
| 366 |
6-Bromo-androstan-3,17-dione |
USCSA,H.R.4771,recent |
| 336 |
4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol |
USCSA,H.R.4771,recent |
| 338 |
4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol |
USCSA,H.R.4771,recent |
| 350 |
4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione |
USCSA,H.R.4771,recent |
| 336 |
4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one |
USCSA,H.R.4771,recent |
| 339 |
Clonazolam |
recent,unclassified |
| 348 |
CUMYL-PICA |
recent,cannabinoid |
| 273 |
3-Desoxy-3,4-methylendioxypyrovalerone |
cathinone,recent |
| 318 |
Diclazepam |
recent,unclassified |
| 318 |
2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one |
USCSA,H.R.4771,recent |
| 203 |
5-EAPB |
phenethylamine,recent |
| 391 |
EG 018 |
recent,cannabinoid |
| 409 |
EG2201 |
recent,cannabinoid |
| 569 |
Eluxadoline |
unclassified,proposed,recent |
| 320 |
2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol |
USCSA,H.R.4771,recent |
| 268 |
Estra-4,9,11-triene-3,17-dione |
USCSA,H.R.4771,recent |
| 332 |
Flubromazepam |
recent,unclassified |
| 370 |
Flubromazolam |
recent,unclassified |
| 195 |
3-Fluorophenmetrazine |
recent,unclassified |
| 383 |
FUB-AMB |
cannabinoid,recent |
| 316 |
[3,2-/c]-Furazan-5α-androstan-17β-ol |
USCSA,H.R.4771,recent |
| 286 |
18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one |
USCSA,H.R.4771,recent |
| 315 |
17β-Hydroxy-androstano[2,3-/d]isoxazole |
USCSA,H.R.4771,recent |
| 315 |
17β-Hydroxy-androstano[3,2-/c]isoxazole |
USCSA,H.R.4771,recent |
| 302 |
4-Hydroxy-androst-4-ene-3,17-dione[3,2-/c]pyrazole-5α-androstan-17β-ol |
USCSA,H.R.4771,recent |
| 270 |
3β-Hydroxy-estra-4,9,11-trien-17-one |
USCSA,H.R.4771,recent |
| 358 |
β-Hydroxythiofentanyl |
unclassified,recent |
| 370 |
MAB-CHMINACA |
cannabinoid,recent,proposed |
| 371 |
MA-CHMINACA |
cannabinoid,recent |
| 189 |
5-MAPB |
phenethylamine,recent |
| 203 |
5-MBPB |
phenethylamine,recent |
| 384 |
MDMB-CHMICA |
cannabinoid,recent |
| 385 |
MDMB-CHMINACA |
cannabinoid,recent |
| 397 |
MDMB-FUBINACA |
recent,cannabinoid |
| 237 |
5-Methoxy methylone |
recent,cathinone |
| 302 |
17α-Methyl-androsta-1,4-diene-3,17β-diol |
USCSA,H.R.4771,recent |
| 319 |
17α-Methyl-androstan-3-hydroxyimine-17β-ol |
USCSA,H.R.4771,recent |
| 290 |
17α-Methyl-5α-androstan-17β-ol |
USCSA,H.R.4771,recent |
| 304 |
17α-Methyl-androst-2-ene-3,17β-diol |
USCSA,H.R.4771,recent |
| 300 |
6α-Methyl-androst-4-ene-3,17-dione |
USCSA,H.R.4771,recent |
| 207 |
Mexedrone |
recent,cathinone |
| 386 |
MO-CHMINACA |
cannabinoid,recent |
| 637 |
Naloxegol |
USCSA,unclassified,recent |
| 375 |
NM-2201 |
cannabinoid,recent |
| 245 |
PV-7 |
recent,cathinone |
| 395 |
PX1 |
cannabinoid,recent |
| 396 |
PX2 |
cannabinoid,recent |
| 404 |
PX3 |
cannabinoid,recent |
| 312 |
[3,2-/c]Pyrazole-androst-4-en-17β-ol |
USCSA,H.R.4771,recent |
| 376 |
W-15 |
unclassified,recent |
•
Updated 31 August 2016
